Education
About Us
Working with TipRanks
Follow Us
Exicure (XCUR)
:XCUR
XCUR Stock Chart & Stats
$4.54
-$0.13(-1.36%)
At close: 4:00 PM EST
$4.54
-$0.13(-1.36%)
Day’s Range― - ―
52-Week Range$2.57 - $36.00
Previous CloseN/A
Volume39.94K
Average Volume (3M)29.85K
Market Cap
$26.85M
Enterprise ValueN/A
Total Cash (Recent Filing)$7.86M
Total Debt (Recent Filing)$476.00K
Price to Earnings (P/E)―
Beta1.43
Next Earnings
May 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding6,317,816
10 Day Avg. Volume13,221
30 Day Avg. Volume29,853
Financial Highlights & Ratios
PEG Ratio0.35
Price to Book (P/B)12.31
Price to Sales (P/S)166.76
P/FCF Ratio-28.65
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Exicure News
XCUR FAQ
What was Exicure’s price range in the past 12 months?
Exicure lowest stock price was $2.57 and its highest was $36.00 in the past 12 months.
What is Exicure’s market cap?
Exicure’s market cap is $26.85M.
When is Exicure’s upcoming earnings report date?
Exicure’s upcoming earnings report date is May 20, 2026 which is in 192 days.
How were Exicure’s earnings last quarter?
Exicure released its earnings results on Nov 07, 2025. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.39.
Is Exicure overvalued?
According to Wall Street analysts Exicure’s price is currently Overvalued.
Does Exicure pay dividends?
Exicure does not currently pay dividends.
What is Exicure’s EPS estimate?
Exicure’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Exicure have?
Exicure has 6,317,816 shares outstanding.
What happened to Exicure’s price movement after its last earnings report?
Exicure reported an EPS of -$0.39 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.824%.
Which hedge fund is a major shareholder of Exicure?
Currently, no hedge funds are holding shares in XCUR
Company Description
Exicure
Exicure (XCUR) is a biotechnology company focused on developing innovative therapeutics based on its proprietary spherical nucleic acid (SNA) technology platform. Operating in the pharmaceutical and biotechnology sectors, Exicure aims to address unmet medical needs through the development of gene regulatory and immuno-oncology therapeutics. The company's core products are designed to leverage the unique properties of SNA to enhance target engagement and improve therapeutic outcomes.
Technical Analysis
ESSA Pharma
―
I-MAB
―
Unicycive Therapeutics
―
Caribou Biosciences
―
Vigil Neuroscience Inc
―
Ownership Overview
52.77% Insiders
0.69% Mutual Funds
4.46% Other Institutional Investors
41.55% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---